Diethylpropion
Centrally Acting Antiobesity Products
- Drug class
- Centrally Acting Antiobesity Products
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 4
Overview
Plain-language summary, compiled from the cited regulatory records
Diethylpropion is a medication classified as a centrally acting antiobesity product [1]. It is approved for short-term use as part of a weight reduction program that includes caloric restriction [1]. This medication is intended for patients with a body mass index (BMI) of 30 kg/m² or higher who have not achieved sufficient weight loss through diet and exercise alone [1].
Diethylpropion is available as extended-release tablets [1]. It is sold under several brand names [1].
This medication is intended for use as a short-term adjunct, typically for a few weeks, in conjunction with a comprehensive weight management plan [1].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 4 | May 29, 2026 |
USUnited States· FDA
4 products
Uses
INDICATIONS AND USAGE
Diethylpropion hydrochloride extended release tablets, 75 mg are indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone.
Below is a chart of BMI based on various heights and weights. BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. 0254 = meters. Body Mass Index (BMI), kg/m 2 Weight (pounds) Height (feet, inches) 5’0” 5’3” 5’6” 5’9” 6’0” 6’3” 140 27 25 23 21 19 18 150 29 27 24 22 20 19 160 31 28 26 24 22 20 170 33 30 28 25 23 21 180 35 32 29 27 25 23 190 37 34 31 28 26 24 200 39 36 32 30 27 25 210 41 37 34 31 29 26 220 43 39 36 33 30 28 230 45 41 37 34 31 29 240 47 43 39 36 33 30 250 49 44 40 37 34 31 The usefulness of agents of this class (See CLINICAL PHARMACOLOGY ) should be measured against possible risk factors inherent in their use such as those described below.
Drug interactions
Known interactions involving Diethylpropion. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 04f1a804-00f1-48… · revised May 29, 2026 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.